Skip to content

Air Pollution and Health of COPD Patients

Effect of Air Pollution on Prognosis of Patients With Chronic Obstructive Pulmonary Disease and Its Underlying Biological Mechanism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05076630
Enrollment
110
Registered
2021-10-13
Start date
2021-10-12
Completion date
2024-12-31
Last updated
2025-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Air pollution, chronic obstructive pulmonary disease, cardiopulmonary health, biological mechanism

Brief summary

This panel study aims to evaluate the effects of air pollutants on cardiopulmonary health of patients with chronic obstructive pulmonary disease (COPD) and explore the potential biological mechanisms.

Detailed description

This panel study was conducted in a group of stable patients with COPD in Beijing, China. The health measurements including lung function, blood pressure and airway inflammation were conducted, and morning urine, exhaled breath condensate, saliva and venous blood were collected at the time of enrollment and at 3, 6 and 9 months after enrollment. Individual exposures to fine particulate matter (PM2.5), black carbon (BC), ozone (O3) and nitrogen dioxide (NO2) were performed for 24 hours at each follow-up. And the daily concentrations of air pollutants were collected from the Beijing Air Quality Real-time Publishing Platform and meteorological data were collected from the National Meteorological Information Center. The linear mixed effects model was used to analyze the association between air pollution and cardiopulmonary health in patients with COPD.

Interventions

OTHERAir pollutants

Particulate matter and gaseous pollutants

Sponsors

Peking University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* doctor-diagnosed stable COPD patients * aged 40 to 80 years * lived in Beijing for over one year before being recruited * Agree to participate and sign the informed consent form.

Exclusion criteria

* Patients with a history of acute exacerbation in the last 1 month * Patients with other respiratory diseases such as bronchiectasis and asthma.

Design outcomes

Primary

MeasureTime frameDescription
Lung functionNine monthsLung function test was conducted.

Secondary

MeasureTime frameDescription
Modified British Medical Research Council (mMRC) Questionnaire scoreNine monthsModified British Medical Research Council (mMRC) Questionnaire score was used to assess the severity of dyspnea on a scale of 0 to 4, with a higher score indicating a worse outcome.
ST. George's Respiratory Questionnaire scoresNine monthsST. George's Respiratory Questionnaire (SGRQ) scores were used to assess quality of life in patients with COPD on a scale of 0 to 100, with higher scores indicating poorer outcomes.
Blood pressureNine monthsSystolic and diastolic blood pressure of participants were measured at least three times by a trained technician.
COPD Assessment Test scoresNine monthsCOPD Assessment Test (CAT) scores were used to assess quality of life in COPD patients on a scale of 0 to 40, with higher scores associated with poorer outcomes.
Airway and systemic oxidative stress levelsNine monthsExhaled Breath Condensate (EBC) and urine samples were collected for oxidative stress analysis.
Systemic inflammationNine monthsVenous blood was collected for determination of systemic inflammatory biomarkers.
Respiratory inflammationNine monthsFractional exhaled nitric oxide (FeNO) test was conducted.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026